VEGFA and age-related macular degeneration: The anti-VEGF monoclonal antibodies that were used to treat AMD include the approved intravitreal administration of pegaptanib, ranibizumab, and aflibercept and the off-label intravitreal administration of bevacizumab and Ziv-aflibercept [6,7].